2.9 |
11.7 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
2.4 |
7.1 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
2.3 |
11.7 |
GO:0007068 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
2.1 |
12.5 |
GO:0030421 |
defecation(GO:0030421) |
2.0 |
10.1 |
GO:1990169 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.9 |
22.6 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
1.9 |
1.9 |
GO:0090191 |
negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.9 |
7.5 |
GO:0060594 |
mammary gland specification(GO:0060594) |
1.9 |
5.6 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.9 |
16.7 |
GO:0032348 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.8 |
7.4 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
1.8 |
5.4 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
1.7 |
6.9 |
GO:0051796 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
1.7 |
5.1 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
1.7 |
3.4 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
1.6 |
3.3 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
1.6 |
4.7 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
1.5 |
4.6 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.4 |
4.1 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) |
1.4 |
1.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
1.4 |
4.1 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
1.3 |
1.3 |
GO:0060948 |
cardiac vascular smooth muscle cell development(GO:0060948) |
1.3 |
3.9 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.3 |
3.8 |
GO:2000349 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
1.2 |
10.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
1.1 |
6.9 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
1.1 |
3.4 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
1.1 |
2.3 |
GO:0019827 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
1.1 |
1.1 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
1.1 |
1.1 |
GO:0061098 |
regulation of protein tyrosine kinase activity(GO:0061097) positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.1 |
4.4 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
1.1 |
13.1 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.1 |
3.3 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
1.0 |
2.1 |
GO:0033131 |
regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
1.0 |
5.1 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
1.0 |
6.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
1.0 |
4.0 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.0 |
3.0 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
1.0 |
5.0 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
1.0 |
3.0 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
1.0 |
6.9 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.0 |
2.9 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
1.0 |
2.9 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
1.0 |
2.9 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.0 |
2.9 |
GO:0010160 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
1.0 |
3.8 |
GO:0060166 |
olfactory pit development(GO:0060166) |
1.0 |
4.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
1.0 |
9.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
0.9 |
7.5 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
0.9 |
6.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
0.9 |
1.9 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
0.9 |
3.7 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.9 |
4.6 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.9 |
2.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 |
4.6 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
0.9 |
1.8 |
GO:0032353 |
negative regulation of hormone biosynthetic process(GO:0032353) |
0.9 |
3.6 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.9 |
2.7 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
0.9 |
2.6 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
0.9 |
2.6 |
GO:0042938 |
dipeptide transport(GO:0042938) |
0.9 |
5.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
0.8 |
2.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.8 |
2.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.8 |
4.2 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
0.8 |
2.5 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 |
2.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
0.8 |
5.0 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.8 |
31.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
0.8 |
0.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 |
4.8 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.8 |
7.2 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
0.8 |
0.8 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
0.8 |
11.8 |
GO:0060613 |
fat pad development(GO:0060613) |
0.8 |
2.3 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.8 |
0.8 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
0.8 |
5.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
0.8 |
4.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
0.8 |
0.8 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
0.8 |
3.0 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
0.7 |
1.5 |
GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
0.7 |
3.0 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 |
0.7 |
GO:0021644 |
vagus nerve morphogenesis(GO:0021644) |
0.7 |
2.9 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
0.7 |
2.2 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
0.7 |
4.4 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.7 |
13.7 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 |
1.4 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.7 |
2.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
0.7 |
0.7 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.7 |
16.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.7 |
9.9 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.7 |
1.4 |
GO:1905069 |
allantois development(GO:1905069) |
0.7 |
2.8 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.7 |
2.1 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.7 |
4.8 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.7 |
2.8 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 |
7.6 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
0.7 |
3.4 |
GO:0021557 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.7 |
2.0 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
0.7 |
2.7 |
GO:1903860 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.7 |
6.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
0.7 |
1.3 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
0.7 |
5.9 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.7 |
2.6 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
0.7 |
3.9 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.7 |
3.9 |
GO:1990834 |
response to odorant(GO:1990834) |
0.6 |
1.9 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
0.6 |
3.9 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
0.6 |
1.9 |
GO:0046730 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.6 |
3.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.6 |
1.9 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
0.6 |
2.5 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
0.6 |
1.3 |
GO:1901185 |
negative regulation of ERBB signaling pathway(GO:1901185) |
0.6 |
1.9 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
0.6 |
3.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
0.6 |
3.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.6 |
1.9 |
GO:0048627 |
myoblast development(GO:0048627) |
0.6 |
0.6 |
GO:0006907 |
pinocytosis(GO:0006907) |
0.6 |
2.5 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.6 |
3.7 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 |
1.8 |
GO:2000742 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.6 |
1.2 |
GO:0061643 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.6 |
0.6 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
0.6 |
1.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
0.6 |
1.8 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 |
5.4 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
0.6 |
1.8 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.6 |
0.6 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
0.6 |
1.2 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
0.6 |
3.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
0.6 |
0.6 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
0.6 |
2.9 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.6 |
4.6 |
GO:0030578 |
PML body organization(GO:0030578) |
0.6 |
0.6 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
0.6 |
9.6 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
0.6 |
1.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
0.6 |
2.2 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.6 |
0.6 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 |
10.6 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.6 |
1.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
0.6 |
0.6 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
0.6 |
0.6 |
GO:0090274 |
regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.5 |
4.9 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
0.5 |
1.6 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
0.5 |
0.5 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
0.5 |
2.7 |
GO:0030807 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.5 |
1.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 |
1.6 |
GO:1901656 |
glycoside transport(GO:1901656) |
0.5 |
2.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
0.5 |
5.3 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.5 |
2.6 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
0.5 |
0.5 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
0.5 |
0.5 |
GO:0002085 |
inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.5 |
2.6 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 |
0.5 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.5 |
3.6 |
GO:0070417 |
cellular response to cold(GO:0070417) |
0.5 |
6.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
0.5 |
2.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.5 |
2.0 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
0.5 |
2.5 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.5 |
2.5 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
0.5 |
1.5 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.5 |
1.5 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
0.5 |
3.5 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
0.5 |
0.5 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
0.5 |
2.0 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
0.5 |
3.9 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 |
8.3 |
GO:0035878 |
nail development(GO:0035878) |
0.5 |
3.9 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
0.5 |
1.5 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.5 |
4.8 |
GO:2001205 |
negative regulation of osteoclast development(GO:2001205) |
0.5 |
8.2 |
GO:0015871 |
choline transport(GO:0015871) |
0.5 |
7.2 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.5 |
1.0 |
GO:0001300 |
chronological cell aging(GO:0001300) |
0.5 |
1.0 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
0.5 |
0.5 |
GO:1903008 |
organelle disassembly(GO:1903008) |
0.5 |
3.8 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
0.5 |
2.3 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.5 |
2.3 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
0.5 |
1.9 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
0.5 |
1.4 |
GO:2001201 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) regulation of transforming growth factor-beta secretion(GO:2001201) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
0.5 |
3.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
0.5 |
1.4 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 |
1.8 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 |
1.4 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 |
0.9 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.5 |
1.8 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.5 |
4.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
0.5 |
1.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
0.4 |
6.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 |
1.8 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
0.4 |
1.3 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 |
2.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 |
2.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
0.4 |
1.8 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
0.4 |
1.8 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
0.4 |
4.4 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
0.4 |
1.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 |
8.3 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.4 |
7.4 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.4 |
3.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
0.4 |
10.0 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
0.4 |
4.3 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.4 |
4.3 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 |
1.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
0.4 |
6.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
0.4 |
1.3 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
0.4 |
1.3 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.4 |
0.9 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 |
5.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
0.4 |
1.7 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
0.4 |
1.3 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
0.4 |
2.5 |
GO:1901909 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 |
1.3 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
0.4 |
2.9 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.4 |
0.8 |
GO:0032796 |
uropod organization(GO:0032796) |
0.4 |
1.2 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 |
0.4 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 |
1.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
0.4 |
1.2 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
0.4 |
0.4 |
GO:0021897 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.4 |
0.8 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
0.4 |
1.2 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
0.4 |
0.4 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
0.4 |
0.8 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 |
1.6 |
GO:0072553 |
terminal button organization(GO:0072553) |
0.4 |
4.9 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
0.4 |
4.4 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
0.4 |
1.6 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
0.4 |
2.4 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 |
1.6 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
0.4 |
1.6 |
GO:0009956 |
radial pattern formation(GO:0009956) |
0.4 |
1.2 |
GO:0021718 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.4 |
3.5 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.4 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
0.4 |
0.4 |
GO:0051645 |
Golgi localization(GO:0051645) |
0.4 |
1.2 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.4 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.4 |
4.6 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 |
1.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.4 |
1.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 |
3.4 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 |
5.0 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
0.4 |
0.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
0.4 |
1.5 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.4 |
1.9 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
0.4 |
3.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.4 |
0.4 |
GO:0046959 |
habituation(GO:0046959) |
0.4 |
0.8 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.4 |
1.5 |
GO:0090325 |
regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.4 |
9.3 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 |
0.7 |
GO:0015808 |
L-alanine transport(GO:0015808) |
0.4 |
1.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
0.4 |
1.1 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
0.4 |
0.7 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
0.4 |
1.5 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 |
0.4 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
0.4 |
0.7 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.4 |
2.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.4 |
0.7 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 |
4.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
0.4 |
1.1 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
0.4 |
0.7 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
0.4 |
2.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
0.4 |
1.1 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 |
1.8 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
0.4 |
1.1 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.4 |
1.4 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
0.4 |
1.4 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
0.4 |
0.4 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
0.4 |
1.4 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
0.4 |
8.1 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
0.4 |
1.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
0.4 |
4.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
0.3 |
1.7 |
GO:1904450 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.3 |
0.7 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
0.3 |
0.3 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.3 |
3.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.3 |
1.4 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
0.3 |
0.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
0.3 |
1.0 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 |
0.7 |
GO:0006788 |
heme oxidation(GO:0006788) |
0.3 |
4.4 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
0.3 |
1.7 |
GO:0044856 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.3 |
2.0 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
0.3 |
3.7 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
0.3 |
2.4 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
0.3 |
4.4 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
0.3 |
0.7 |
GO:0032196 |
transposition(GO:0032196) |
0.3 |
1.4 |
GO:0032752 |
response to molecule of fungal origin(GO:0002238) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
0.3 |
2.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 |
0.3 |
GO:1902680 |
positive regulation of RNA biosynthetic process(GO:1902680) |
0.3 |
4.0 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 |
3.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 |
0.3 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
0.3 |
14.0 |
GO:0071276 |
cellular response to cadmium ion(GO:0071276) |
0.3 |
1.0 |
GO:0021503 |
neural fold bending(GO:0021503) |
0.3 |
1.3 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 |
0.7 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
0.3 |
1.0 |
GO:1902565 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.3 |
5.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.3 |
4.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
0.3 |
0.3 |
GO:0060547 |
negative regulation of necrotic cell death(GO:0060547) |
0.3 |
1.6 |
GO:0070295 |
renal water absorption(GO:0070295) |
0.3 |
2.6 |
GO:0042471 |
ear morphogenesis(GO:0042471) |
0.3 |
2.6 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.3 |
1.0 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 |
4.2 |
GO:0003264 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.3 |
3.3 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
0.3 |
2.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
0.3 |
1.9 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 |
7.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
0.3 |
1.0 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
0.3 |
1.6 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 |
5.1 |
GO:0015074 |
DNA integration(GO:0015074) |
0.3 |
1.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
0.3 |
3.2 |
GO:0044821 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 |
2.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 |
5.7 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 |
0.3 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
0.3 |
1.6 |
GO:0006696 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.3 |
0.3 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
0.3 |
0.6 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 |
2.2 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 |
0.3 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
0.3 |
0.3 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 |
2.8 |
GO:0072189 |
ureter development(GO:0072189) |
0.3 |
1.6 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
0.3 |
1.3 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
0.3 |
0.6 |
GO:0071806 |
protein transmembrane transport(GO:0071806) |
0.3 |
1.2 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
0.3 |
0.9 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
0.3 |
5.3 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 |
4.0 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
0.3 |
0.6 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
0.3 |
2.2 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.3 |
6.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 |
0.6 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
0.3 |
1.5 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
0.3 |
0.6 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.3 |
0.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
0.3 |
1.5 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
0.3 |
1.5 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 |
7.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
0.3 |
3.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
0.3 |
0.3 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
0.3 |
3.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
0.3 |
1.5 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 |
8.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 |
0.9 |
GO:1901254 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
0.3 |
3.8 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
0.3 |
0.9 |
GO:0070638 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.3 |
0.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
0.3 |
0.3 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 |
1.2 |
GO:0016333 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.3 |
1.8 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
0.3 |
1.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.3 |
1.5 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 |
0.9 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
0.3 |
5.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 |
4.4 |
GO:0046697 |
decidualization(GO:0046697) |
0.3 |
0.6 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
0.3 |
0.6 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
0.3 |
1.2 |
GO:0032228 |
regulation of synaptic transmission, GABAergic(GO:0032228) |
0.3 |
2.3 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
0.3 |
2.8 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
0.3 |
7.4 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 |
2.3 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 |
0.6 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
0.3 |
5.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
0.3 |
0.8 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.3 |
0.8 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
0.3 |
1.1 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.3 |
0.6 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
0.3 |
2.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
0.3 |
4.7 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
0.3 |
3.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
0.3 |
0.3 |
GO:0060629 |
meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
0.3 |
1.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
0.3 |
9.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.3 |
0.3 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.3 |
0.5 |
GO:0014040 |
positive regulation of Schwann cell differentiation(GO:0014040) |
0.3 |
0.8 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 |
1.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 |
7.4 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 |
1.1 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 |
3.8 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
0.3 |
1.9 |
GO:0030432 |
peristalsis(GO:0030432) |
0.3 |
1.6 |
GO:0007141 |
male meiosis I(GO:0007141) |
0.3 |
3.5 |
GO:0015705 |
iodide transport(GO:0015705) |
0.3 |
0.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
0.3 |
0.8 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.3 |
2.9 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
0.3 |
0.8 |
GO:0050894 |
determination of affect(GO:0050894) |
0.3 |
7.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
0.3 |
0.8 |
GO:0072537 |
fibroblast activation(GO:0072537) |
0.3 |
0.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
0.3 |
1.3 |
GO:0075509 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 |
2.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 |
0.3 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 |
1.1 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
0.3 |
1.3 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
0.3 |
1.1 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
0.3 |
1.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
0.3 |
1.8 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
0.3 |
3.4 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
0.3 |
1.0 |
GO:0044334 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 |
1.8 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
0.3 |
1.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
0.3 |
0.3 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
0.3 |
1.6 |
GO:2000537 |
regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.3 |
2.3 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.3 |
0.3 |
GO:0032328 |
alanine transport(GO:0032328) |
0.3 |
1.8 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
0.3 |
2.6 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.3 |
1.0 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
0.3 |
1.0 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.3 |
0.3 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
0.3 |
1.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.3 |
0.5 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 |
2.3 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
0.3 |
1.8 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.3 |
0.5 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
0.3 |
1.0 |
GO:1904647 |
response to rotenone(GO:1904647) |
0.3 |
2.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 |
2.0 |
GO:0001842 |
neural fold formation(GO:0001842) |
0.3 |
0.5 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
0.3 |
1.0 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.3 |
5.0 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
0.3 |
2.5 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
0.3 |
0.5 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
0.2 |
1.0 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
0.2 |
1.0 |
GO:0072185 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.2 |
1.0 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 |
0.2 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
0.2 |
1.7 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
0.2 |
0.2 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
0.2 |
1.2 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
0.2 |
1.7 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
0.2 |
0.7 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
0.2 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
0.2 |
1.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 |
1.0 |
GO:1903232 |
melanosome assembly(GO:1903232) |
0.2 |
0.7 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
0.2 |
1.0 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.2 |
1.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
0.2 |
0.5 |
GO:0031116 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.2 |
1.2 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
0.2 |
0.7 |
GO:0030451 |
regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
0.2 |
1.2 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) |
0.2 |
1.0 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
0.2 |
0.2 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
0.2 |
1.9 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.2 |
0.9 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.2 |
0.9 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
0.2 |
0.5 |
GO:0010616 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 |
0.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 |
1.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
0.2 |
0.7 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) |
0.2 |
1.9 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
0.2 |
0.2 |
GO:0006477 |
protein sulfation(GO:0006477) |
0.2 |
0.7 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 |
1.4 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.2 |
0.7 |
GO:0071301 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.2 |
3.7 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
0.2 |
0.2 |
GO:0042231 |
interleukin-13 biosynthetic process(GO:0042231) |
0.2 |
0.7 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.2 |
3.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
0.2 |
0.7 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 |
0.5 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.2 |
4.1 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
0.2 |
2.5 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
0.2 |
4.1 |
GO:0015816 |
glycine transport(GO:0015816) |
0.2 |
0.5 |
GO:0036511 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 |
0.2 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
0.2 |
0.7 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
0.2 |
0.2 |
GO:0010481 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 |
1.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
0.2 |
2.7 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
0.2 |
1.1 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 |
2.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 |
1.4 |
GO:0060180 |
female mating behavior(GO:0060180) |
0.2 |
2.0 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 |
1.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 |
1.3 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
0.2 |
6.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 |
0.2 |
GO:0060039 |
pericardium development(GO:0060039) |
0.2 |
0.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
0.2 |
0.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
0.2 |
1.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
0.2 |
0.4 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 |
0.2 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 |
0.9 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.2 |
0.4 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.2 |
1.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
0.2 |
0.9 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
0.2 |
3.0 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
0.2 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
0.2 |
1.7 |
GO:0070141 |
response to UV-A(GO:0070141) |
0.2 |
0.6 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
0.2 |
1.3 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
0.2 |
0.2 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
0.2 |
0.6 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
0.2 |
0.4 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
0.2 |
0.4 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
0.2 |
0.2 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.2 |
0.9 |
GO:0001835 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 |
1.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.2 |
4.3 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 |
1.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 |
0.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
0.2 |
0.6 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 |
0.2 |
GO:0032925 |
regulation of activin receptor signaling pathway(GO:0032925) |
0.2 |
0.2 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
0.2 |
0.6 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
0.2 |
0.6 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
0.2 |
3.2 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
0.2 |
0.6 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 |
0.6 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 |
0.6 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 |
0.4 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
0.2 |
2.5 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 |
0.4 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 |
0.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
0.2 |
0.2 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
0.2 |
0.2 |
GO:1902075 |
cellular response to salt(GO:1902075) |
0.2 |
0.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 |
0.4 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
0.2 |
0.6 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
0.2 |
0.4 |
GO:0060323 |
head morphogenesis(GO:0060323) |
0.2 |
2.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
0.2 |
2.7 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 |
1.7 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 |
0.2 |
GO:0031946 |
regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.2 |
0.6 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 |
0.2 |
GO:0035425 |
autocrine signaling(GO:0035425) |
0.2 |
1.9 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
0.2 |
0.8 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
0.2 |
0.8 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
0.2 |
1.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
0.2 |
2.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
0.2 |
2.9 |
GO:0021702 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 |
1.6 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
0.2 |
2.0 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
0.2 |
6.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
0.2 |
1.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
0.2 |
2.0 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 |
0.6 |
GO:0002894 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.2 |
0.6 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 |
0.8 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
0.2 |
0.2 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
0.2 |
0.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
0.2 |
0.6 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
0.2 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 |
0.2 |
GO:0042119 |
neutrophil activation(GO:0042119) |
0.2 |
0.4 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
0.2 |
0.4 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
0.2 |
1.4 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
0.2 |
1.0 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 |
0.4 |
GO:0060717 |
chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.2 |
0.8 |
GO:0036114 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 |
1.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
0.2 |
1.0 |
GO:0061055 |
myotome development(GO:0061055) |
0.2 |
1.8 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 |
1.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
0.2 |
0.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 |
2.6 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 |
0.8 |
GO:0060573 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 |
0.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
0.2 |
0.8 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 |
1.4 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
0.2 |
0.8 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
0.2 |
0.6 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
0.2 |
1.2 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 |
1.9 |
GO:0097503 |
sialylation(GO:0097503) |
0.2 |
2.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
0.2 |
3.5 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
0.2 |
2.3 |
GO:0003360 |
brainstem development(GO:0003360) |
0.2 |
3.7 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
0.2 |
2.3 |
GO:2000582 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 |
1.0 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 |
0.6 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
0.2 |
1.1 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) positive regulation of blood vessel remodeling(GO:2000504) |
0.2 |
0.2 |
GO:0061010 |
gall bladder development(GO:0061010) |
0.2 |
0.2 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
0.2 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 |
5.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.2 |
0.6 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 |
0.8 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
0.2 |
3.6 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
0.2 |
0.4 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.2 |
1.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
0.2 |
2.2 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
0.2 |
8.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
0.2 |
1.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.2 |
0.6 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 |
0.6 |
GO:0090650 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 |
0.9 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 |
2.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
0.2 |
0.7 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
0.2 |
8.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
0.2 |
0.7 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.2 |
1.5 |
GO:0060051 |
negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
0.2 |
2.9 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.2 |
0.9 |
GO:0035900 |
response to isolation stress(GO:0035900) |
0.2 |
0.5 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
0.2 |
0.2 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
0.2 |
0.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 |
0.7 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.2 |
4.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
0.2 |
2.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
0.2 |
2.6 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.2 |
0.7 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
0.2 |
1.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 |
2.1 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
0.2 |
17.0 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 |
3.5 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 |
0.9 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
0.2 |
0.7 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
0.2 |
1.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
0.2 |
0.2 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
0.2 |
0.7 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
0.2 |
0.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
0.2 |
1.0 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) |
0.2 |
0.5 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
0.2 |
0.5 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 |
0.5 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
0.2 |
1.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
0.2 |
2.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
0.2 |
0.5 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
0.2 |
0.5 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
0.2 |
1.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
0.2 |
0.9 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
0.2 |
0.7 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.2 |
1.4 |
GO:0001893 |
maternal placenta development(GO:0001893) |
0.2 |
0.9 |
GO:0048749 |
compound eye development(GO:0048749) |
0.2 |
1.0 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 |
0.5 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
0.2 |
8.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 |
0.5 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.2 |
0.7 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
0.2 |
0.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
0.2 |
0.5 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
0.2 |
0.7 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
0.2 |
0.3 |
GO:0097477 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.2 |
1.8 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.2 |
0.8 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
0.2 |
0.7 |
GO:0014072 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.2 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
0.2 |
0.5 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 |
0.5 |
GO:1903513 |
endoplasmic reticulum to cytosol transport(GO:1903513) |
0.2 |
1.8 |
GO:0060056 |
mammary gland involution(GO:0060056) |
0.2 |
0.3 |
GO:0015800 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.2 |
0.3 |
GO:0036269 |
swimming behavior(GO:0036269) |
0.2 |
0.7 |
GO:0060992 |
response to fungicide(GO:0060992) |
0.2 |
0.3 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
0.2 |
1.0 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 |
1.3 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.2 |
0.8 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 |
1.1 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 |
0.2 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
0.2 |
0.5 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.2 |
1.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
0.2 |
2.9 |
GO:0097320 |
membrane tubulation(GO:0097320) |
0.2 |
0.8 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
0.2 |
1.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
0.2 |
0.2 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
0.2 |
0.8 |
GO:0042695 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 |
0.6 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
0.2 |
1.6 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 |
0.5 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
0.2 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
0.2 |
1.1 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 |
0.8 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 |
5.1 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
0.2 |
1.7 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.2 |
0.6 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 |
3.6 |
GO:0014733 |
regulation of skeletal muscle adaptation(GO:0014733) |
0.2 |
0.5 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
0.2 |
2.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
0.2 |
0.6 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
0.2 |
0.6 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 |
1.2 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
0.2 |
0.5 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 |
1.1 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
0.2 |
0.6 |
GO:0048511 |
rhythmic process(GO:0048511) |
0.2 |
0.8 |
GO:0001315 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 |
0.2 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
0.2 |
0.2 |
GO:0007632 |
visual behavior(GO:0007632) |
0.2 |
0.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
0.2 |
1.7 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
0.2 |
3.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
0.2 |
1.8 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
0.2 |
1.2 |
GO:2001197 |
positive regulation of extracellular matrix assembly(GO:1901203) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 |
0.8 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
0.2 |
0.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 |
0.3 |
GO:0031016 |
pancreas development(GO:0031016) |
0.1 |
2.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
0.1 |
1.2 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 |
1.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
0.1 |
1.6 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
0.1 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 |
0.4 |
GO:0008291 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) acetylcholine metabolic process(GO:0008291) negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) acetate ester metabolic process(GO:1900619) |
0.1 |
0.4 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
0.1 |
0.4 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 |
0.1 |
GO:0032763 |
regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
0.1 |
0.6 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 |
0.4 |
GO:0032917 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 |
0.3 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
0.1 |
1.2 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.1 |
0.3 |
GO:0002673 |
regulation of acute inflammatory response(GO:0002673) |
0.1 |
2.2 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 |
3.9 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
0.1 |
1.3 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 |
0.7 |
GO:2000406 |
positive regulation of T cell migration(GO:2000406) |
0.1 |
0.4 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
0.1 |
3.3 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
0.1 |
0.4 |
GO:0061026 |
cardiac muscle tissue regeneration(GO:0061026) |
0.1 |
2.9 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 |
0.1 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 |
0.6 |
GO:0098911 |
regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 |
2.4 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
0.1 |
0.3 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 |
0.6 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
0.1 |
0.4 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
0.1 |
1.1 |
GO:0003383 |
apical constriction(GO:0003383) |
0.1 |
0.4 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
0.1 |
0.8 |
GO:0048747 |
muscle fiber development(GO:0048747) |
0.1 |
0.8 |
GO:0072660 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.1 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 |
0.4 |
GO:1990519 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 |
0.7 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 |
1.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
0.1 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
0.1 |
0.3 |
GO:0042418 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.1 |
0.3 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 |
4.8 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.1 |
0.8 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
0.1 |
0.5 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
0.1 |
1.0 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 |
0.7 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 |
0.7 |
GO:0016240 |
autophagosome docking(GO:0016240) |
0.1 |
0.5 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 |
0.1 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 |
0.7 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 |
0.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 |
0.4 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
0.1 |
3.9 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 |
0.5 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 |
0.3 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.1 |
0.4 |
GO:0035349 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.1 |
0.5 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 |
0.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
0.1 |
0.8 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 |
0.1 |
GO:1901993 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.1 |
0.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
0.1 |
1.3 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 |
0.9 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
0.1 |
0.4 |
GO:0089709 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.1 |
0.1 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
0.1 |
2.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 |
0.5 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 |
1.2 |
GO:1990144 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 |
0.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 |
0.1 |
GO:0098917 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
0.1 |
2.3 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
0.1 |
0.6 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.1 |
1.0 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
0.1 |
0.5 |
GO:1903238 |
positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.1 |
0.4 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 |
1.3 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 |
0.9 |
GO:0090494 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
0.1 |
0.4 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
0.1 |
0.4 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
0.1 |
0.4 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 |
1.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
0.1 |
0.9 |
GO:0097647 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 |
1.0 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 |
1.4 |
GO:0045732 |
positive regulation of protein catabolic process(GO:0045732) |
0.1 |
1.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
0.1 |
0.5 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 |
1.0 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
0.1 |
0.9 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 |
0.1 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 |
0.1 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
0.1 |
1.6 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
0.1 |
0.2 |
GO:1904350 |
regulation of protein catabolic process in the vacuole(GO:1904350) |
0.1 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 |
1.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
0.1 |
3.1 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
0.1 |
1.0 |
GO:0032439 |
endosome localization(GO:0032439) |
0.1 |
0.1 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 |
0.7 |
GO:0072695 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 |
0.7 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
0.1 |
0.2 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
0.1 |
0.5 |
GO:2000553 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 |
0.5 |
GO:0018343 |
protein farnesylation(GO:0018343) |
0.1 |
2.9 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
0.1 |
0.5 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
0.1 |
0.4 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
0.1 |
0.7 |
GO:0001502 |
cartilage condensation(GO:0001502) |
0.1 |
0.5 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 |
0.2 |
GO:1900138 |
negative regulation of phospholipase A2 activity(GO:1900138) |
0.1 |
0.7 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 |
0.5 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
0.1 |
2.4 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
0.1 |
1.4 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 |
0.5 |
GO:0038001 |
paracrine signaling(GO:0038001) |
0.1 |
0.6 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 |
0.5 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
0.1 |
2.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
0.1 |
2.9 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
0.1 |
0.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.1 |
0.3 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.1 |
2.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
0.1 |
1.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
0.1 |
0.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
0.1 |
0.8 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
0.1 |
0.9 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 |
0.3 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
0.1 |
5.5 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
0.1 |
0.3 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
0.1 |
1.0 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
0.1 |
0.9 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
0.1 |
0.2 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 |
0.6 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
0.1 |
0.4 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.1 |
1.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
0.1 |
0.7 |
GO:0072077 |
renal vesicle formation(GO:0072033) renal vesicle morphogenesis(GO:0072077) |
0.1 |
1.3 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
0.1 |
0.4 |
GO:0051198 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 |
0.4 |
GO:0009386 |
translational attenuation(GO:0009386) |
0.1 |
1.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.1 |
0.9 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 |
0.2 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
0.1 |
0.9 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
0.1 |
0.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
0.1 |
0.3 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 |
0.4 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 |
0.7 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 |
0.2 |
GO:0046885 |
regulation of hormone biosynthetic process(GO:0046885) |
0.1 |
1.4 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
0.1 |
0.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 |
0.6 |
GO:1900424 |
regulation of defense response to bacterium(GO:1900424) |
0.1 |
2.5 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 |
1.8 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 |
1.5 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 |
3.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
0.1 |
0.3 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
0.1 |
2.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
0.1 |
5.1 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
0.1 |
1.6 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
0.1 |
0.1 |
GO:0045777 |
positive regulation of blood pressure(GO:0045777) |
0.1 |
0.4 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 |
0.1 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
0.1 |
0.5 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
0.1 |
1.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 |
0.7 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.1 |
0.1 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
0.1 |
0.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 |
1.5 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
0.1 |
2.5 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
0.1 |
1.0 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
0.1 |
0.9 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
0.1 |
2.2 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
0.1 |
4.5 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
0.1 |
1.5 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
0.1 |
0.2 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.1 |
0.3 |
GO:0098728 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 |
0.4 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 |
1.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 |
0.2 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) |
0.1 |
2.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
0.1 |
0.8 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.1 |
0.3 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) DNA dephosphorylation(GO:0098502) |
0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
0.1 |
0.1 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
0.1 |
0.2 |
GO:0051665 |
membrane raft localization(GO:0051665) |
0.1 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 |
1.4 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
0.1 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
0.1 |
0.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
0.1 |
0.5 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
0.1 |
0.1 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
0.1 |
1.6 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 |
0.2 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
0.1 |
0.5 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 |
0.7 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
0.1 |
0.1 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
0.1 |
0.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
0.1 |
1.7 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
0.1 |
0.3 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 |
0.5 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
0.1 |
0.1 |
GO:0015965 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 |
0.1 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
0.1 |
0.8 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 |
0.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
0.1 |
1.0 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 |
0.1 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
0.1 |
1.0 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
0.1 |
0.1 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
0.1 |
1.0 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
0.1 |
0.7 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
0.1 |
0.9 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
0.1 |
0.1 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
0.1 |
0.4 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 |
0.6 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
0.1 |
0.5 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
0.1 |
0.1 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 |
0.2 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 |
6.5 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
0.1 |
0.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
0.1 |
0.7 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 |
1.0 |
GO:0034333 |
adherens junction assembly(GO:0034333) |
0.1 |
0.4 |
GO:0051836 |
translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.1 |
0.2 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
0.1 |
0.3 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 |
1.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
0.1 |
0.3 |
GO:0071048 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.1 |
0.1 |
GO:0000393 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 |
0.5 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
0.1 |
0.2 |
GO:0014028 |
notochord formation(GO:0014028) |
0.1 |
0.1 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 |
0.7 |
GO:0043032 |
positive regulation of macrophage activation(GO:0043032) |
0.1 |
0.5 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
0.1 |
1.9 |
GO:0002385 |
mucosal immune response(GO:0002385) |
0.1 |
0.4 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
0.1 |
1.7 |
GO:1903391 |
regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of adherens junction organization(GO:1903391) |
0.1 |
0.1 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 |
0.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.1 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
0.1 |
0.3 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
0.1 |
0.6 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 |
1.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
0.1 |
1.9 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
0.1 |
6.0 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 |
0.4 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
0.1 |
0.5 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 |
0.9 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
0.1 |
0.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 |
0.2 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
0.1 |
0.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
0.1 |
0.8 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
0.1 |
0.9 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
0.1 |
0.3 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 |
0.2 |
GO:0009216 |
purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) adenosine biosynthetic process(GO:0046086) |
0.1 |
0.1 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
0.1 |
0.6 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
0.1 |
0.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 |
0.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
0.1 |
0.2 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 |
0.1 |
GO:1901382 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.1 |
0.2 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
0.1 |
0.7 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
0.1 |
0.6 |
GO:0006687 |
glycosphingolipid metabolic process(GO:0006687) |
0.1 |
0.2 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.1 |
0.3 |
GO:0032376 |
positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 |
0.1 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 |
0.6 |
GO:0008218 |
bioluminescence(GO:0008218) |
0.1 |
1.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
0.1 |
0.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 |
0.4 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
0.1 |
0.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
0.1 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 |
0.3 |
GO:0072600 |
establishment of protein localization to Golgi(GO:0072600) |
0.1 |
0.3 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
0.1 |
0.6 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
0.1 |
0.1 |
GO:0001942 |
hair follicle development(GO:0001942) |
0.1 |
0.7 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 |
0.2 |
GO:0090220 |
chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 |
1.2 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
0.1 |
0.5 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 |
0.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 |
0.2 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 |
0.6 |
GO:0042220 |
response to cocaine(GO:0042220) |
0.1 |
0.1 |
GO:1904292 |
regulation of ERAD pathway(GO:1904292) |
0.1 |
1.2 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
0.1 |
0.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 |
1.8 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
0.1 |
0.2 |
GO:0010193 |
response to ozone(GO:0010193) |
0.1 |
0.2 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.1 |
0.2 |
GO:0045839 |
negative regulation of mitotic nuclear division(GO:0045839) |
0.1 |
1.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
0.1 |
0.5 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
0.1 |
0.2 |
GO:0009642 |
response to light intensity(GO:0009642) |
0.1 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
0.1 |
0.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
0.1 |
2.4 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 |
0.5 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 |
1.5 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
0.1 |
0.4 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
0.1 |
0.1 |
GO:1900084 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
0.1 |
0.4 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 |
0.2 |
GO:0050810 |
regulation of steroid biosynthetic process(GO:0050810) |
0.1 |
1.0 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
0.1 |
0.2 |
GO:0042311 |
vasodilation(GO:0042311) |
0.1 |
2.6 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
0.1 |
0.3 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
0.1 |
1.6 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
0.1 |
0.1 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 |
0.5 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) histone mRNA catabolic process(GO:0071044) |
0.1 |
0.1 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
0.1 |
1.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
0.1 |
1.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 |
0.2 |
GO:1990910 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.1 |
0.5 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 |
0.4 |
GO:1905214 |
regulation of RNA binding(GO:1905214) |
0.1 |
0.1 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
0.1 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 |
1.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
0.1 |
0.9 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 |
0.7 |
GO:0014894 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 |
0.4 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 |
0.6 |
GO:0071514 |
genetic imprinting(GO:0071514) |
0.1 |
1.4 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 |
0.7 |
GO:0006489 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.1 |
0.3 |
GO:0051581 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 |
0.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
0.1 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
0.1 |
0.3 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 |
0.4 |
GO:0001705 |
ectoderm formation(GO:0001705) |
0.1 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
0.1 |
0.1 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
0.1 |
0.2 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
0.1 |
0.7 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
0.1 |
0.1 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 |
0.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.1 |
0.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 |
0.1 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
0.1 |
0.4 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
0.1 |
0.2 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
0.1 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 |
4.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
0.1 |
0.5 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 |
0.3 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 |
0.4 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 |
1.5 |
GO:0003341 |
cilium movement(GO:0003341) |
0.1 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
0.1 |
1.1 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 |
1.5 |
GO:0045861 |
negative regulation of proteolysis(GO:0045861) |
0.1 |
0.7 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.1 |
0.1 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
0.1 |
0.1 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 |
0.4 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 |
0.3 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
0.1 |
0.7 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
0.1 |
0.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
0.1 |
0.8 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
0.1 |
0.5 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 |
0.3 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 |
0.8 |
GO:0036065 |
fucosylation(GO:0036065) |
0.1 |
0.1 |
GO:0030540 |
female genitalia development(GO:0030540) neutrophil clearance(GO:0097350) |
0.1 |
0.2 |
GO:0033320 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 |
0.3 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
0.1 |
0.2 |
GO:0006043 |
glucosamine catabolic process(GO:0006043) |
0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.1 |
0.1 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 |
4.3 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
0.1 |
1.0 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
0.1 |
0.4 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 |
0.1 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 |
0.2 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
0.1 |
0.4 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
0.1 |
0.8 |
GO:0032570 |
response to progesterone(GO:0032570) |
0.1 |
0.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
0.1 |
0.2 |
GO:0090195 |
chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) |
0.1 |
0.5 |
GO:0051013 |
microtubule severing(GO:0051013) |
0.1 |
0.2 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
0.1 |
0.8 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 |
0.1 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
0.1 |
3.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
0.1 |
0.2 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 |
1.2 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 |
0.4 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
0.1 |
0.2 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 |
1.5 |
GO:0048490 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 |
0.7 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
0.1 |
0.3 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 |
4.4 |
GO:0090114 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 |
0.4 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
0.1 |
0.4 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
0.1 |
1.1 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
0.1 |
0.3 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
0.1 |
10.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 |
0.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.1 |
0.8 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
0.1 |
0.4 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
0.1 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
0.1 |
0.5 |
GO:0016926 |
protein desumoylation(GO:0016926) |
0.1 |
0.9 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
0.1 |
0.2 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
0.1 |
0.1 |
GO:0051464 |
positive regulation of cortisol secretion(GO:0051464) |
0.1 |
0.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
0.1 |
0.8 |
GO:0014850 |
response to muscle activity(GO:0014850) |
0.1 |
0.1 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
0.1 |
0.4 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
0.1 |
0.2 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 |
0.3 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
0.1 |
0.1 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
0.1 |
0.3 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 |
2.4 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
0.1 |
0.4 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
0.1 |
0.1 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
0.1 |
0.2 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 |
0.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 |
0.3 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
0.1 |
0.3 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
0.1 |
0.2 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
0.1 |
0.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
0.1 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
0.1 |
0.5 |
GO:0002068 |
glandular epithelial cell development(GO:0002068) |
0.1 |
0.2 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
0.1 |
0.2 |
GO:0010269 |
response to selenium ion(GO:0010269) |
0.1 |
0.6 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
0.1 |
0.7 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 |
0.2 |
GO:0051413 |
response to cortisone(GO:0051413) |
0.1 |
0.1 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 |
0.6 |
GO:0097205 |
renal filtration(GO:0097205) |
0.1 |
0.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 |
1.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 |
0.8 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
0.1 |
0.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 |
0.1 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
0.1 |
0.6 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
0.1 |
0.7 |
GO:0071467 |
cellular response to pH(GO:0071467) |
0.1 |
0.5 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
0.1 |
1.4 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
0.1 |
0.2 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
0.1 |
0.5 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 |
3.8 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 |
0.2 |
GO:0003281 |
ventricular septum development(GO:0003281) |
0.1 |
0.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
0.1 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
0.1 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.1 |
0.2 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 |
1.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 |
0.4 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 |
1.7 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
0.0 |
0.3 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.0 |
0.7 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
0.0 |
0.2 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 |
0.4 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
0.0 |
0.2 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.0 |
0.4 |
GO:0045901 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 |
0.7 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
0.0 |
0.1 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
0.0 |
0.4 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
0.0 |
0.3 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
0.0 |
0.0 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
0.0 |
0.7 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
0.0 |
0.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 |
0.4 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 |
0.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 |
0.0 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
0.0 |
0.0 |
GO:0021561 |
facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.0 |
0.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
0.0 |
0.4 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 |
0.2 |
GO:0097475 |
motor neuron migration(GO:0097475) |
0.0 |
1.1 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
0.0 |
0.2 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 |
1.6 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 |
0.9 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
0.0 |
1.2 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 |
1.0 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
0.0 |
0.0 |
GO:0010660 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of muscle cell apoptotic process(GO:0010660) |
0.0 |
0.2 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
0.0 |
0.1 |
GO:0071450 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 |
0.0 |
GO:0044691 |
tooth eruption(GO:0044691) |
0.0 |
1.2 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 |
0.1 |
GO:1904587 |
response to glycoprotein(GO:1904587) |
0.0 |
1.2 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
0.0 |
0.5 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
0.0 |
0.2 |
GO:0051904 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.0 |
0.2 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 |
0.4 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.0 |
0.2 |
GO:0021783 |
preganglionic parasympathetic fiber development(GO:0021783) |
0.0 |
0.8 |
GO:0050779 |
RNA destabilization(GO:0050779) |
0.0 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
0.0 |
0.5 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
0.0 |
0.3 |
GO:0006569 |
tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.0 |
1.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
0.0 |
0.2 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
0.0 |
0.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
0.0 |
0.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 |
0.1 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
0.0 |
0.2 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
0.0 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 |
0.0 |
GO:0070233 |
negative regulation of T cell apoptotic process(GO:0070233) |
0.0 |
0.3 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
0.0 |
0.3 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
0.0 |
0.3 |
GO:0001821 |
histamine secretion(GO:0001821) |
0.0 |
0.2 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
0.0 |
0.3 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
0.0 |
0.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
0.0 |
1.8 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
0.0 |
0.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
0.0 |
0.5 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 |
0.3 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
0.0 |
0.6 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
0.0 |
0.2 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
0.0 |
0.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
0.0 |
0.1 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
0.0 |
0.1 |
GO:0009597 |
detection of virus(GO:0009597) |
0.0 |
1.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 |
1.3 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
0.0 |
0.1 |
GO:0007616 |
long-term memory(GO:0007616) |
0.0 |
0.2 |
GO:1900003 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 |
0.1 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 |
0.1 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
0.0 |
0.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
0.0 |
0.2 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 |
0.2 |
GO:0045007 |
depurination(GO:0045007) |
0.0 |
0.2 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
0.0 |
0.2 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
0.0 |
0.1 |
GO:1900151 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 |
0.3 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 |
0.0 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
0.0 |
0.0 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
0.0 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
0.0 |
0.7 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.0 |
0.2 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 |
0.4 |
GO:0015747 |
urate transport(GO:0015747) |
0.0 |
0.0 |
GO:0002573 |
myeloid leukocyte differentiation(GO:0002573) |
0.0 |
0.2 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 |
0.1 |
GO:0043105 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.0 |
0.3 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 |
0.2 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
0.0 |
0.1 |
GO:0050892 |
intestinal absorption(GO:0050892) |
0.0 |
0.2 |
GO:0060602 |
branch elongation of an epithelium(GO:0060602) |
0.0 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
0.0 |
2.2 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 |
0.8 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
0.0 |
0.3 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
0.0 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
0.0 |
0.2 |
GO:0071352 |
cellular response to interleukin-2(GO:0071352) |
0.0 |
0.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
0.0 |
0.2 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
0.0 |
0.1 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 |
1.1 |
GO:0007492 |
endoderm development(GO:0007492) |
0.0 |
0.3 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
0.0 |
1.7 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 |
0.0 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
0.0 |
0.2 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
0.0 |
0.1 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
0.0 |
0.6 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
0.0 |
0.2 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
0.0 |
0.4 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 |
0.3 |
GO:0002293 |
alpha-beta T cell activation involved in immune response(GO:0002287) alpha-beta T cell differentiation involved in immune response(GO:0002293) |
0.0 |
0.1 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 |
0.4 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
0.0 |
0.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
0.0 |
0.2 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
0.0 |
0.1 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 |
1.6 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
0.0 |
0.1 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.0 |
0.1 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
0.0 |
1.0 |
GO:0006305 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
0.0 |
0.1 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.0 |
0.1 |
GO:0031629 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
0.0 |
0.9 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
0.0 |
0.0 |
GO:0042222 |
interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
0.0 |
0.1 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
0.0 |
0.6 |
GO:0008213 |
protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 |
3.6 |
GO:0070268 |
cornification(GO:0070268) |
0.0 |
0.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
0.0 |
0.1 |
GO:1901899 |
positive regulation of relaxation of cardiac muscle(GO:1901899) |
0.0 |
0.2 |
GO:0019363 |
NADP biosynthetic process(GO:0006741) nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 |
0.1 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
0.0 |
1.3 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
0.0 |
0.2 |
GO:0001553 |
luteinization(GO:0001553) |
0.0 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
0.0 |
0.1 |
GO:0043627 |
response to estradiol(GO:0032355) response to estrogen(GO:0043627) |
0.0 |
0.2 |
GO:0022615 |
protein import into peroxisome matrix, docking(GO:0016560) protein to membrane docking(GO:0022615) |
0.0 |
0.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
0.0 |
2.1 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
0.0 |
0.2 |
GO:0015755 |
fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 |
0.2 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
0.0 |
0.1 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
0.0 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
0.0 |
0.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 |
0.1 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
0.0 |
0.1 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
0.0 |
0.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
0.0 |
1.8 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.0 |
0.1 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 |
0.2 |
GO:0019086 |
late viral transcription(GO:0019086) |
0.0 |
0.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
0.0 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
0.0 |
0.0 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 |
0.1 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 |
0.3 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 |
0.1 |
GO:0032222 |
regulation of synaptic transmission, cholinergic(GO:0032222) |
0.0 |
0.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
0.0 |
0.2 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
0.0 |
0.3 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
0.0 |
0.1 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 |
0.1 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 |
0.1 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
0.0 |
0.1 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
0.0 |
0.0 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
0.0 |
0.3 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
0.0 |
1.4 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 |
0.1 |
GO:0051801 |
cytolysis by symbiont of host cells(GO:0001897) hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.0 |
0.1 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 |
0.0 |
GO:0060318 |
regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.0 |
0.4 |
GO:0001562 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.0 |
0.5 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 |
0.2 |
GO:0098927 |
vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 |
0.0 |
GO:0002442 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.0 |
0.0 |
GO:0046824 |
positive regulation of nucleocytoplasmic transport(GO:0046824) |
0.0 |
0.1 |
GO:0021902 |
forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 |
0.2 |
GO:0009584 |
detection of visible light(GO:0009584) |
0.0 |
0.0 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.0 |
0.3 |
GO:0006903 |
vesicle targeting(GO:0006903) |
0.0 |
0.2 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 |
1.0 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
0.0 |
0.0 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 |
0.0 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
0.0 |
0.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 |
0.1 |
GO:0071599 |
otic vesicle development(GO:0071599) |
0.0 |
0.5 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 |
0.1 |
GO:0042308 |
negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 |
0.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
0.0 |
0.0 |
GO:0045346 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 |
0.0 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
0.0 |
0.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.0 |
2.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
0.0 |
0.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.0 |
0.0 |
GO:0072678 |
T cell migration(GO:0072678) |
0.0 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
0.0 |
0.3 |
GO:0097242 |
beta-amyloid clearance(GO:0097242) |
0.0 |
0.1 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.0 |
0.0 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
0.0 |
0.1 |
GO:0043113 |
receptor clustering(GO:0043113) |
0.0 |
0.4 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
0.0 |
0.2 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
0.0 |
0.5 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
0.0 |
0.0 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
0.0 |
1.1 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.0 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
0.0 |
0.1 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
0.0 |
0.0 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
0.0 |
0.0 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 |
0.1 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 |
0.1 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
0.0 |
0.1 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
0.0 |
0.1 |
GO:0090504 |
epiboly(GO:0090504) |
0.0 |
0.5 |
GO:0090383 |
phagosome acidification(GO:0090383) |
0.0 |
3.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
0.0 |
0.1 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
0.0 |
3.2 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
0.0 |
0.1 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
0.0 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
0.0 |
0.1 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
0.0 |
0.2 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
0.0 |
0.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
0.0 |
0.1 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
0.0 |
0.1 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 |
0.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 |
0.2 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 |
0.2 |
GO:0031638 |
zymogen activation(GO:0031638) |
0.0 |
0.1 |
GO:0040014 |
regulation of multicellular organism growth(GO:0040014) |
0.0 |
0.1 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
0.0 |
0.1 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
0.0 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
0.0 |
0.1 |
GO:0043584 |
nose development(GO:0043584) |
0.0 |
0.1 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
0.0 |
0.1 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
0.0 |
0.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
0.0 |
0.0 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
0.0 |
0.1 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
0.0 |
0.1 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
0.0 |
0.0 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 |
0.0 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
0.0 |
0.0 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
0.0 |
0.2 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
0.0 |
0.0 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 |
0.4 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.0 |
0.2 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
0.0 |
0.2 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
0.0 |
0.1 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
0.0 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 |
0.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
0.0 |
0.0 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 |
0.1 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
0.0 |
0.0 |
GO:0070875 |
positive regulation of glycogen metabolic process(GO:0070875) |
0.0 |
0.2 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 |
0.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
0.0 |
0.2 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
0.0 |
0.0 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
0.0 |
0.0 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
0.0 |
0.0 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
0.0 |
0.0 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
0.0 |
0.0 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 |
0.1 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.0 |
0.0 |
GO:0048806 |
genitalia development(GO:0048806) |
0.0 |
0.2 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
0.0 |
0.0 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
0.0 |
0.0 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
0.0 |
0.0 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
0.0 |
0.1 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
0.0 |
0.0 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 |
0.1 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
0.0 |
0.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
0.0 |
0.0 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 |
0.3 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 |
0.2 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
0.0 |
0.2 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
0.0 |
0.2 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
0.0 |
0.0 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
0.0 |
0.1 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 |
0.1 |
GO:0044236 |
multicellular organism metabolic process(GO:0044236) |
0.0 |
0.0 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |